OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT

OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT

Introduction: Autologous stem cell transplantation (ASCT) following high-dose chemotherapy is applied for patients with relapsed/refractory (r/r) DLBCL. However, prognosis of relapsing DLBCL post-ASCT remained poor until the availability of CAR-T cell treatment. To appreciate this development, unde...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ulrike Bacher, Stefanie von Matt, Yara Banz, Behrouz Mansouri Taleghani, Urban Novak, Thomas Pabst
Format:	Article
Language:	English
Published:	PAGEPress Publications 2023-04-01
Series:	Mediterranean Journal of Hematology and Infectious Diseases
Subjects:	autologous stem cell transplantation (ASCT) diffuse large B-cell lymphoma (DLBCL)
Online Access:	http://www.mjhid.org/index.php/mjhid/article/view/5244
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Autologous stem cell transplantation in adults with atypical teratoid rhabdoid tumor: a case report and review
by: Jackson Griffith-Linsley, et al.
Published: (2024-12-01)

FEASIBILITY AND OUTCOME OF FIRST-LINE AUTOTRANSPLANT-BASED TREATMENT IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS AGED > 65 YEARS: MONOCENTRIC RETROSPECTIVE REAL-WORLD ANALYSIS
by: Paola Stefanoni, et al.
Published: (2024-08-01)

CURRENT ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA
by: Luca Castagna, et al.
Published: (2015-02-01)

Hyper-fractionated radiotherapy as a bridging strategy to enhance CAR-T efficacy by regulating T-cell co-stimulatory molecules in relapsed/refractory diffuse large B-cell lymphoma
by: Jing Ruan, et al.
Published: (2024-12-01)

Enteropathy‐associated T‐cell lymphoma: A population‐based cohort study on incidence, treatment, and outcome in the Netherlands
by: Frederik O. Meeuwes, et al.
Published: (2024-12-01)

EAM conditioning regimen followed by autologous hematopoietic Stem Cell Transplantation for relapsed, refractory and high risk lymphomas
by: Mohamed BEKADJA, et al.
Published: (2014-08-01)

AUTOLOGOUS STEM CELL TRANSPLANTATION IN ELDERLY ACUTE MYELOID LEUKEMIA
by: Gert J. Ossenkoppele, et al.
Published: (2013-02-01)

High-Dose Chemotherapy and Autologous or Allogeneic Transplantation in Aggressive B-Cell Lymphoma—Is There Still a Role?
by: Michael Daunov, et al.
Published: (2024-10-01)

Cryopreservation of Hematopoietic Stem Cells for Pediatric Autologous Stem Cell Transplantation
by: Rasika Dhawan Setia, et al.
Published: (2024-11-01)

REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY
by: Ulrike Bacher, et al.
Published: (2021-01-01)

Autologous Hematopoietic Cell Transplant as an Effective Treatment Modality for Systemic Sclerosis and Multiple Myeloma
by: Memon H, et al.
Published: (2025-01-01)

Autologous stem cell transplantation in patients older than 65 years with multiple myeloma: a real-world study
by: Cristian Maximiliano Seehaus, et al.
Published: (2024-12-01)

THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
by: Francesco Maura, et al.
Published: (2016-09-01)

Application of autologous hemopoietic stem cells in inoperable patients with chronic critical lower limb ischemia
by: I. P. Mikhaylov, et al.
Published: (2022-04-01)

Tandem Versus Single Autologous Stem Cell Transplantation for High‐Risk Multiple Myeloma in the Era of Novel Agents: A Real‐World Study of China
by: Xuelin Dou, et al.
Published: (2025-01-01)

Outcome of autologous bone marrow transplant in patients with relapsed and refractory diffuse large B-cell lymphoma in relation with prognostic factor: A single-center experience
by: Fawaz Salim Yousif, et al.
Published: (2024-12-01)

Predictive factors of thrombosis during autologous stem cell transplantation in multiple myeloma: Experience from EHU Oran (Algeria)
by: Mohammed Amine BEKADJA, et al.
Published: (2022-06-01)

Predictive factors of thrombosis during autologous stem cell transplantation in multiple myeloma: Experience from EHU Oran (Algeria)
by: Mohammed Amine BEKADJA, et al.
Published: (2022-06-01)

Busulfan and cyclophosphamide for autologous stem cell transplantation in patients with multiple myeloma after proteasome inhibitor and/or immunomodulatory drug treatment
by: Min Ji Jeon, et al.
Published: (2024-11-01)

Trial watch: bispecific antibodies for the treatment of relapsed or refractory large B-cell lymphoma
by: Giulio Cassanello, et al.
Published: (2024-12-01)

UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA
by: Patrizia Tosi, et al.
Published: (2012-11-01)

UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA
by: Patrizia Tosi, et al.
Published: (2012-01-01)

Relapse of Diffuse Large B‐Cell Lymphoma as Painless Masses in the Abdominal Wall Muscles: A Rare Case Report
by: Somar Mansour, et al.
Published: (2025-01-01)

Real-world outcomes of maintenance therapy post-autologous stem cell transplantation in newly diagnosed multiple myeloma
by: Ka-Won Kang, et al.
Published: (2025-02-01)

Case report: A novel third-generation anti-CD19/CD22 CAR T-cells combined with auto-HSCT for relapsed Burkitt lymphoma
by: Xiaodan Luo, et al.
Published: (2024-12-01)

Chidamide plus R‐GDP for relapsed/refractory diffuse large B‐cell lymphoma in patients ineligible for autologous transplantation: A prospective, single‐arm, phase II study
by: Guang‐Liang Chen, et al.
Published: (2024-08-01)

The perspectives of autologous hepatocytes generation for the treatment of liver failure
by: M. N. Evseeva, et al.
Published: (2015-12-01)

Analysis of early efficacy and immune reconstitution after autologous hematopoietic stem cell transplantation in multiple myeloma
by: Kaili Chen, et al.
Published: (2025-01-01)

Real-world use of tafasitamab preceding CD19-directed chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma
by: Narendranath Epperla, et al.
Published: (2025-01-01)

Bacterial contamination of autologous blood salvaged during deceased donor liver transplantation: a prospective observational study
by: Doyeon Kim, et al.
Published: (2024-11-01)

Induction Chemotherapy‐Related Covert Cardiac Remodeling in Pre‐Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma: A Retrospective Observational Study
by: Chang Dai, et al.
Published: (2024-11-01)

Efficacy of autologous stem cells for bone regeneration during endosseous dental implants insertion - A systematic review of human studies
by: Shailesh Varshney, et al.
Published: (2020-10-01)

ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: Angelo Michele Carella
Published: (2012-10-01)

Clinical Trial: Effect of Autologous Dendritic Cell Administration on Improving Neuropathy Symptoms and Inflammatory Biomarkers in Diabetic Neuropathy
by: Erwin Setiawan, et al.
Published: (2024-12-01)

Impact of circulating lymphoma cells at diagnosis on outcomes in patients with newly diagnosed de novo diffuse large B-cell lymphoma
by: Sayan Mullick Chowdhury, et al.
Published: (2025-01-01)

正常妊娠和子痫前期胎盘Syncytin 表达差异探讨
Published: (2009-01-01)

Role of mesenchymal cells in enhancing cosmetic outcomes for autologous augmented fat transfers for facial rejuvenation and reconstructive surgery
by: Soroush Ansari Lari, et al.
Published: (2024-11-01)

Autologous fat grafting for postoperative breast reconstruction: A systemic review
by: Wenxin Yu, et al.
Published: (2024-06-01)

Impact of gut colonization by antibiotic-resistant bacteria on the outcomes of autologous stem cell transplantation in multiple myeloma
by: Marcin Jasiński, et al.
Published: (2024-12-01)

Outcomes of upfront plerixafor use for mobilization in germ cell tumor patients
by: Jaimie Cohen, et al.
Published: (2024-11-01)